Related Experiment Video
Updated: Aug 2, 2026

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening
Published on: July 18, 2012
[Determination of the minimum inhibitory concentration of fluconazole against Cryptococcus neoformans]
C M Fernández Andreu1, T Pimentel Turino, G Martínez Machín
1ciipk@infomed.sld.cu
Abstract:
The minimum inhibitory concentration of fluconozole was determined in 36 strains of Cryptococcus neoformans var. neoformans by a casitone broth microdilution method, taking into account that it is one of the most used antifungal agents in our country for the treatment of cryptococcal meningitis, the second opportunistic mycosis in order of frequency and that with the highest lethality among AIDS patients. The minimum inhibitory concentration of the studied strains ranged 0.125 to more than 64 micrograms/mL for a geometrical mean of 2.38 micrograms/mL. 50% of the strains were inhibited with 4 micrograms/mL and the least concentration that inhibited 90% was 16 micrograms/mL. It is stressed the importance of continuing this type of in vitro studies to detect the appearance of resistance of C. neoformans to antifungal agents.
Insights
This study determined fluconazole
Area of Science:
- Medical Mycology
- Antimicrobial Resistance
Background:
- Cryptococcus neoformans meningitis is a severe opportunistic infection, particularly in AIDS patients.
- Fluconazole is a primary antifungal treatment in many regions.
- Monitoring antifungal susceptibility is crucial for effective treatment.
Purpose of the Study:
- To determine the minimum inhibitory concentration (MIC) of fluconazole against Cryptococcus neoformans var. neoformans.
- To assess the in vitro susceptibility of clinical isolates to a widely used antifungal agent.
Main Methods:
- Casitone broth microdilution method was employed.
- 36 strains of Cryptococcus neoformans var. neoformans were tested.
- Minimum Inhibitory Concentrations (MICs) were quantified.
Main Results:
- MICs ranged from 0.125 to >64 µg/mL, with a geometric mean of 2.38 µg/mL.
- 50% of strains were inhibited by 4 µg/mL.
- The minimum concentration inhibiting 90% of strains (MIC90) was 16 µg/mL.
Conclusions:
- In vitro fluconazole susceptibility varies among Cryptococcus neoformans strains.
- Continued surveillance for antifungal resistance in C. neoformans is essential.
- These findings inform treatment strategies for cryptococcal meningitis.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Cryptococcal Meningitis

